Skip to main content
logo
CARsgen Therapeutics Holdings Limited (HKG:2171)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.56
-0.24 (-1.62%)
Jul 9, 2026, 4:08 PM HKT

HKG:2171 Revenue

In the year 2025, CARsgen Therapeutics Holdings had annual revenue of 125.66M CNY with 218.74% growth. CARsgen Therapeutics Holdings had revenue of 74.70M in the half year ending December 31, 2025.

Revenue
125.66M CNY
Revenue Growth
+218.74%
P/S Ratio
62.94
Revenue / Employee
353.98K CNY
Employees
355
Market Cap
8.80B HKD

Revenue Chart

Chart
* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025125.66M86.24M218.74%
Dec 31, 202439.43M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 202125.81M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shanghai Haohai Biological Technology2.73B
Everest Medicines1.90B
HBM Holdings1.23B
Lepu Biopharma1.04B
Abbisko Cayman681.17M
Alphamab Oncology630.11M
CStone Pharmaceuticals299.99M
Nanjing Leads Biolabs197.25M
Revenue Rankings

CARsgen Therapeutics Holdings News

More News